TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bachem Holding AG ( (CH:BANB) ) has provided an announcement.
Bachem Holding AG announced the proposal of Dr. Simone Wyss Fedele, CEO of Switzerland Global Enterprise, for election as a new member of its Board of Directors at the upcoming General Meeting in April 2025. Dr. Fedele brings extensive experience in the life sciences industry and international trade, having held leadership roles at Novartis and Takeda Pharmaceuticals. Her addition is expected to enhance Bachem’s strategic positioning and strengthen its board with her international expertise and connections.
More about Bachem Holding AG
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. It provides pharmaceutical and biotech companies worldwide with products for research, clinical development, and commercial application. Headquartered in Switzerland, Bachem operates internationally with locations in Europe, the USA, and Asia, and is listed on the SIX Swiss Exchange.
YTD Price Performance: -12.20%
Average Trading Volume: 20,269
Technical Sentiment Signal: Strong Buy
Current Market Cap: CHF3.87B
For a thorough assessment of BANB stock, go to TipRanks’ Stock Analysis page.